Search

Eric Ng, PhD, and Jaya Rajaiya, PhD, have been accepted to attend the 2017 HMS Leadership Development Course for Physicians and Scientists on March 29-31, 2017. This annual course offered by the Harvard Office for Faculty Affairs is designed for HMS and HSDM instructors, assistant professors, and...

Elizabeth (Lizzy) Rossin, MD, PhD, currently a second year resident, has been selected Chief Resident and Director of the Mass. Eye and Ear Eye Trauma Service for the academic year 2018-2019. In this vital role, Dr. Rossin will oversee one of the busiest ocular trauma centers in the country and...

Congratulations to Viridiana Kocaba and Shivakumar Vasanth (co-first author with Takashi Miyai) for their abstracts selected for paper presentation at ARVO 2017 annual meeting in Baltimore, MD. Both presentations are scheduled for May 10, between 8:30-10:15am in room 308 (Session number: 409; title...

Fan Zhang recently completed here doctoral degree at Worcester Polytechnic Institute, and is now joining our team to serve on the Accelerating Medicines Partnership as a Research Scientist.

Emma Davenport recently completed her doctoral degree at the University of Oxford, and is now joining our team.

His primary appointment will be as Senior Research Scientist in Laboratory for Statistical Analysis at the RIKEN Center for Integrative Medical Sciences. He will also have secondary appointments at the University of Shizuoka, where he will serve as Professor and the Department Chief for Clinical...

Grayson Armstrong, MD, MPH, was selected to receive a Massachusetts Society of Eye Physicians and Surgeons (MSEPS) Advocacy Ambassador Travel Grant to attend the AAO’s 2017 Mid-Year Forum in Washington, DC. MSEPS is dedicated to the public’s direct access to ophthalmic care, and to serve the total...

Boston, Mass. — The brains of those who are born blind make new connections in the absence of visual information, resulting in enhanced, compensatory abilities such as a heightened sense of hearing, smell and touch, as well as cognitive functions (such as memory and language) according to a new...

Regulating transcription factor RUNX1 using small molecule drugs a promising novel therapy for diseases of the retina, including advanced diabetic eye disease. Boston, Mass.— A team led by Massachusetts Eye and Ear researchers has identified a novel therapeutic target for retinal neovascularization...